Walgreen will not sell genetic test until maker works out issues with FDA

Wall Street Journal, May 13, 2010

Walgreen Co. said it won't sell an over-the-counter genetic test to consumers until the company that makes the test works out any regulatory issues with the U.S. Food and Drug Administration. The FDA said it had contacted Pathway Genomics about plans to sell a test designed to predict a person's risk for developing diseases or how they might respond to certain drugs. The company announced plans this week to sell its Insight Saliva Collection Kit through 6,000 Walgreens stores, the Wall Street Journal reports.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.